NCT00764712

Brief Summary

A randomized trial to compare three insulin-titration protocols for tight glycemic control in surgical ICU: an absolute glucose (Matias) protocol, a relative glucose change (Bath) protocol, and an enhanced model predictive control algorithm (eMPC)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2008

Completed
Last Updated

March 12, 2012

Status Verified

March 1, 2012

Enrollment Period

2 months

First QC Date

October 1, 2008

Last Update Submit

March 9, 2012

Conditions

Keywords

Tight glycemia controlcardiac surgery patients

Outcome Measures

Primary Outcomes (1)

  • The effectiveness of different TGC management protocols

    ICU stay

Secondary Outcomes (1)

  • The safety with respect to hypoglycemia

    ICU stay

Study Arms (3)

Matias protocol

ACTIVE COMPARATOR

A protocol based on the absolute glucose value - Matias protocol (Matias)

Drug: insulin

Bath protocol

ACTIVE COMPARATOR

A protocol based on the relative glucose change - Bath protocol (Bath)

Drug: insulin

eMPC

ACTIVE COMPARATOR

a computer-based model predictive control algorithm with variable sampling rate (eMPC)

Drug: insulin

Interventions

Insulin was was administered according to each protocol rules/suggestions into a central venous line as a continuous infusion (Bath and eMPC protocols) or as a combination of a continuous infusion and boluses (Matias protocol). A standard concentration of 50 IU of insulin in 50 ml of 0.9% NaCl was used. In all patients, infusion of 10% glucose solution was initiated upon admission to ICU with glucose dose of 2.5 g/kg of ideal body weight (height in centimetres minus 100) per hour and lasted for 18 hours, when normal oral food intake was started. In ventilated patients, the glucose infusion lasted for 48 hours, and then standard enteral nutrition was initiated.

Also known as: Actrapid HM, Novo Nordisk, Baegsvard, Denmark
Bath protocolMatias protocoleMPC

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients admitted to the postoperative ICU after elective cardiac surgery

You may not qualify if:

  • insulin allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital in Prague

Prague, Czechia

Location

Related Publications (1)

  • Blaha J, Kopecky P, Kotulak T, Kunstyr J, Matias M, Rubes D, Dobias M, Romaniv S, Kubatova J, Porizka M et al: Blood glucose control in cardiac surgery patients: a comparative study of different insulin protocols. Journal of Cardiothoracic and Vascular Anesthesia 2008, 22(S3):S23.

    RESULT

MeSH Terms

Conditions

Hyperglycemia

Interventions

Insulin

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

ProinsulinInsulinsPancreatic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Officials

  • Jan Blaha, MD

    Charles University, Czech Republic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 1, 2008

First Posted

October 2, 2008

Study Start

February 1, 2008

Primary Completion

April 1, 2008

Study Completion

April 1, 2008

Last Updated

March 12, 2012

Record last verified: 2012-03

Locations